Novacyt (NCYT) and Yourgene (YGEN) announced that they have reached agreement on the terms and conditions of a recommended cash offer to be made by Novacyt UK, for the entire
Share Talk Weekly Small Cap Movers & Shakers, Saturday 3rd June 2023
Looking at the broader small-cap stock market, the AIM All-Share index dropped 0.55% to 789 points over the trading week, performing slightly worse than its FTSE 100 benchmark, which remained
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 3rd May 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Advanced Oncotherapy, Angus,
Share Talk Weekly Small Cap Movers & Shakers, Saturday 22nd April 2023
Overall, the AIM All-Shares Index closed the week down by half a percent, underperforming against the FTSE 100 and FTSE 350 indices, which both closed around half a percent higher.
RNS Hotlist with Zak Mir: GGP, ANR, SNT, KINO, 1SN, BEM, AVO & VLRM via Vox Markets
Greatland Gold (GGP), a mining development and exploration company, noted the release of an ASX announcement by Newcrest Mining Ltd earlier today providing an update on the Havieron Joint Venture.
Trader’s Cafe with Zak Mir: JAY, POW, EUA, AVO & PHE via Vox Markets
Even in current somewhat curmudgeonly market conditions, it is the case that even with a delay the good news can and does feed into the share price.
Weekend Edition, Bulletin Board Heroes, Sunday 25th April 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Friday 2nd October 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, 2nd August 2020
On Tuesday 11th August at 6pm Share Talk is proud to presents an Investor Webinar and Q & A with Condor Gold PLC. Condor Gold (CNR), is developing the fully
Advanced Oncotherapy (AIM:AVO) Distribution agreement and Equity Investments
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed an exclusive distribution agreement (the “Distribution Agreement”) with Yantai CIPU Medical